Resources and Education for Addressing Chronic Health (REACH) (REACH)

September 9, 2026 updated by: Kelly Harris, Washington University School of Medicine

Piloting REACH - a School-Based Care Coordination Service Model to Support Youth With Asthma: A Systems Approach

This study pilots REACH, Resources and Education for Addressing Chronic Health, a service model to facilitate care coordination and communication across medical, school, and home settings. REACH seeks to address barriers to school-based asthma management, improving health and educational outcomes and reducing negative impacts for children with asthma.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This study develops and tests the REACH intervention which includes (a) a strategic communication or messaging and dissemination strategy to build school and family relationships and trust, (b) capacity building activities to improve asthma knowledge and awareness through asthma education and resources, and (c) a tool/hub that allows record and communication sharing across healthcare and educational systems to facilitate care coordination. Using a Single-Arm Non-Randomized Pre-Post Cluster Trial design, this study tests the hypothesis that use of a care coordination hub will improve school-based asthma management.

Study Type

Interventional

Enrollment (Estimated)

430

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Dr. Kelly M. Harris, PhD, CCC-SLP
  • Phone Number: 314-273-3242
  • Email: kmharris@wustl.edu

Study Contact Backup

Study Locations

    • Missouri
      • St Louis, Missouri, United States, 63110
        • Recruiting
        • WashU School of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Parents (N=200)/Children (N=200)

Inclusion criteria for recruited parents/children:

  • parents/caregivers with at least one child with asthma or present to the nurse with asthma symptoms in the partner school district,
  • child with asthma must have a diagnosis of asthma or suspected asthma due to asthma symptom-related healthcare utilization and/or multiple visits to the school nurse (>1)
  • attend a school in one of the partner school districts
  • have access to email and a computer or other mobile device
  • receive care within the BJH/ WUSM system (an indicator of participation in the electronic health record system).

Exclusion Criteria for recruited families:

  • Child does not have asthma and do not present to school nurse with asthma symptoms
  • Child does not attend one of the identified schools in a partner school district
  • Children in foster care or wards of the state

School Nurses (Implementers) (N=15)

Inclusion Criteria for school nurses:

  • Employed by partner school district and work in an identified building
  • Provide care to students with asthma or present with asthma symptoms

Exclusion Criteria for school nurses:

- Do not work for partner school district or for an identified building

Providers (N =15)

Inclusion Criteria for Providers:

- Provide care to a child participant on the study

Exclusion Criteria for Providers:

- Do not provide care to a child participant on the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: REACH
Consists of school nurses who serve as both participants and REACH intervention implementers, students and their caregivers, and student providers. Though there are several participant types, there is only 1 experimental group. All participants serve as their own controls.
The REACH intervention which includes (a) a strategic communication or messaging and dissemination strategy to build school and family relationships and trust, (b) capacity building activities to improve asthma knowledge and awareness through asthma education and resource provided both digitally and in-person, and (c) a tool or dashboard that allows records and communication sharing across healthcare and educational systems to facilitate care coordination (REACH tool).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Asthma knowledge and awareness
Time Frame: Measured at baseline and at study completion (average of 1 year)
Measured via survey. Data collected from student caregivers and school nurse implementers.
Measured at baseline and at study completion (average of 1 year)
Implementation
Time Frame: Measured at mid-trial (school nurses only) and at study completion (average of 1 year)
Measured via surveys and post-trial semi-structured focus group/interview. Data collected from student caregivers, school nurse implementers, and providers.
Measured at mid-trial (school nurses only) and at study completion (average of 1 year)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Asthma guideline adherence
Time Frame: Measured at baseline and at study completion (average of 1 year)
Measured via survey. Data collected from student caregivers and school nurse implementers.
Measured at baseline and at study completion (average of 1 year)
School connectedness
Time Frame: Measured at baseline and at study completion (average of 1 year)
Measured via survey. Data collected from student caregivers.
Measured at baseline and at study completion (average of 1 year)
Healthcare utilization
Time Frame: 24 months prior to intervention, during intervention, and 12 months following intervention completion
Number of asthma related emergency department visits, hospitalizations, and clinic/office visits collected from the electronic medical record.
24 months prior to intervention, during intervention, and 12 months following intervention completion
School Attendance/Absence
Time Frame: 24 months prior to intervention, during intervention, and 12 months following intervention completion
Number of days student is attends school, and number of school absence days. Data provided by the school.
24 months prior to intervention, during intervention, and 12 months following intervention completion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 9, 2026

Primary Completion (Estimated)

June 1, 2030

Study Completion (Estimated)

June 1, 2030

Study Registration Dates

First Submitted

September 1, 2026

First Submitted That Met QC Criteria

September 9, 2026

First Posted (Actual)

September 15, 2026

Study Record Updates

Last Update Posted (Actual)

September 15, 2026

Last Update Submitted That Met QC Criteria

September 9, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

all IPD that underlie results in a publication

IPD Sharing Time Frame

Beginning 1 year after publication with no end date.

IPD Sharing Access Criteria

Any researcher may request access with a description of the planned use and analyses, and a completed and approved data sharing agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe